CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells
- PMID: 17706641
- DOI: 10.1016/j.yexcr.2007.07.001
CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells
Abstract
The mechanisms leading to renal cell carcinoma (RCC) metastasis are incompletely understood. Although evidence shows that the chemokine receptor CXCR4 and its ligand CXCL12 may regulate tumor dissemination, their role in RCC is not clearly defined. We examined CXCR4 expression and functionality on RCC cell lines, and explored CXCL12-triggered tumor adhesion to human endothelium (HUVEC) or extracellular matrix proteins. Functional CXCR4 was expressed on A498 tumor cells, enabling them to migrate towards a CXCL12 gradient. CXCR4 engagement by CXCL12 induced elevated cell adhesion to HUVEC, to immobilized fibronectin, laminin or collagen. Anti-CXCR4 antibodies or CXCR4 knock down by siRNA applied prior to CXCL12 stimulation impaired CXCL12-triggered tumor adhesion. However, blocking CXCR4 subsequent to CXCL12 stimulation did not. This pointed to an indirect control of tumor cell adhesion by CXCR4. In fact, CXCR4 engagement by CXCL12 also induced alterations of receptors of the integrin family, notably alpha3, alpha5, beta1 and beta3 subunits, and blocking beta1 integrins with a function-blocking antibody prevented CXCL12-induced A498 adhesion. Focal adhesion kinase (total and activated) and integrin-linked kinase significantly increased in CXCL12-treated A498 cells, accompanied by a distinct up-regulation of ERK1/2, JNK and p38 phosphorylation. Therefore, CXCR4 may be crucial in controlling adhesion of A498 cells via cross talking with integrin receptors. These data show that CXCR4 receptors contribute to RCC dissemination and may provide a novel link between CXCR4 chemokine receptor expression and integrin triggered RCC adhesion to the vascular wall and subendothelial matrix components.
Similar articles
-
CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.Neoplasia. 2006 Apr;8(4):290-301. doi: 10.1593/neo.05694. Neoplasia. 2006. PMID: 16756721 Free PMC article.
-
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.Oncogene. 2005 Jun 23;24(27):4462-71. doi: 10.1038/sj.onc.1208621. Oncogene. 2005. PMID: 15806155
-
CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.Cancer Res. 2003 Oct 15;63(20):6751-7. Cancer Res. 2003. PMID: 14583470
-
The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):126-30. J Biol Regul Homeost Agents. 2004. PMID: 15471215 Review.
-
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.Cancer Metastasis Rev. 2006 Dec;25(4):573-87. doi: 10.1007/s10555-006-9019-x. Cancer Metastasis Rev. 2006. PMID: 17165132 Review.
Cited by
-
Clinical Significance of C-X-C Motif Chemokine Receptor 4 and Integrin αvβ6 Expression in Breast Cancer.J Breast Cancer. 2020 Apr;23(2):171-181. doi: 10.4048/jbc.2020.23.e23. J Breast Cancer. 2020. PMID: 32395376 Free PMC article.
-
Effect of integrin α5β1 inhibition on SDF-l/CXCR4-mediated choroidal neovascularization.Int J Ophthalmol. 2018 May 18;11(5):726-735. doi: 10.18240/ijo.2018.05.04. eCollection 2018. Int J Ophthalmol. 2018. PMID: 29862169 Free PMC article.
-
CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins.Int J Cell Biol. 2014;2014:981750. doi: 10.1155/2014/981750. Epub 2014 Dec 15. Int J Cell Biol. 2014. PMID: 25580125 Free PMC article.
-
CXCR4 in breast cancer: oncogenic role and therapeutic targeting.Drug Des Devel Ther. 2015 Aug 28;9:4953-64. doi: 10.2147/DDDT.S84932. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26356032 Free PMC article. Review.
-
[Tumor profiling of renal cell tumors: relevance for diagnostics and therapy].Pathologe. 2009 Mar;30(2):105-10. doi: 10.1007/s00292-008-1112-1. Pathologe. 2009. PMID: 19089427 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous